Tag: Lions Gate Entertainment

  • Mid Cap Unusual Volume: Zions Bancorporation (NASDAQ:ZION), Lions Gate Entertainment (NYSE:LGF), iShares NASDAQ Biotechnology (NASDAQ:IBB), DATA

    Zions Bancorporation (NASDAQ:ZION) was downgraded by analysts at BMO Capital Mkts from an outperform rating to a market perform rating. They currently have $30.00 target price on the stock, down from their previous target price of $32.00. Zions Bancorporation (NASDAQ:ZION) shares after opening at $31.02 moved to $31.51 on last trade day and at the end of the day closed at $30.31. Company price to sales ratio in past twelve months was calculated as 2.88 and price to cash ratio as 0.53. Zions Bancorporation (NASDAQ:ZION) showed a negative weekly performance of -3.50%.

    Lions Gate Entertainment Corp. (USA)(NYSE:LGF) shares were up after the studio’s film “Divergent” had a strong opening at the box office. Many analysts expected a weaker showing for the movie. Lions Gate Entertainment Corp. (USA)(NYSE:LGF) shares advanced 3.84% in last trading session and ended the day on $288.66. LGF return on equity ratio is recorded as 63.30% and its return on assets is 9.60%. Lions Gate Entertainment Corp. (USA)(NYSE:LGF) yearly performance is 28.64%.

    Gilead Sciences (GILD) received complaints alleging overpricing of its hepatitis C drug. It bounced back slightly Monday after being hit hard on Friday. But the group, as illustrated by the iShares Nasdaq Biotechnology (IBB), declined 2.8%. The ETF has fallen 9.5% so far March, but it gained more than 65% in 2013. iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) shares moved down -2.76 % in last trading session and was closed at $239.23 , while trading in range of $232.84 – 247.75 . iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) year to date (YTD) performance is 5.36%.

    Stock analysts at B. Riley assumed coverage on shares of Tableau Software (NYSE:DATA) in a report issued on Wednesday, The Fly OnThe Wall.com reports. The firm set a “buy” rating and a $110.00 price target on the stock. B. Riley’s target price would indicate a potential upside of 22.20% from the stock’s previous close. Tableau Software Inc (NYSE:DATA) weekly performance is -12.20%. On last trading day company shares ended up $79.42. Tableau Software Inc (NYSE:DATA) distance from 50-day simple moving average (SMA50) is -8.30%. Analysts mean target price for the company is $93.50.